Alveo is creating new ways to get diagnostic information to you with be.well™, a test we are developing to provide real-time results to Everyone, Anytime, Everywhere™.
Location: United States, California, San Francisco
Employees: 51-200
Total raised: $38M
Founded date: 2014
Investors 4
Date | Name | Website |
- | Black Diam... | bdventures... |
07.06.2021 | 3E Biovent... | 3ebiovc.co... |
- | Civilizati... | civilizati... |
- | Celesta Ca... | celesta.vc |
Funding Rounds 1
Date | Series | Amount | Investors |
04.01.2018 | Series A | $38M | - |
Mentions in press and media 5
Date | Title | Description | Source |
26.10.2023 | The Week in AgriFoodTech: URB-E pivots to last-mile delivery... | This week, URB-E, a company best known for developing e-scooters, took a sharp left turn with both i... | agfunderne... |
10.07.2020 | Bob Goeltz bolts Unity Biotechnology to become CFO at A... | Bob Goeltz → A press release earlier in the week noted that Bob Goeltz left his CFO post at Uni... | endpts.com... |
30.04.2020 | Alveo partners with Johnson & Johnson to develop in-home... | Johnson & Johnson will help support Alveo through its clinical trials and FDA approvals [Editor... | vator.tv/n... |
08.01.2018 | Alveo Closes $38M in Series A Financing | Alveo Technologies, Inc., a San Francisco, CA-based maker of affordable and accessible infectious di... | finsmes.co... |
04.01.2018 | Alveo Closes $38 Million in Series A Financing to Create Acc... | A recent article on Alveo Technologies $38M Series A – Read the full article | civilizati... |